Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hansoh Pharma
Biotech
Tortugas comes out of shell with $106M, 4 ph. 2-stage neuro meds
A pair of Sage veterans has launched a neurology startup armed with $106 million and a clinical-stage pipeline licensed from Eisai and Hansoh.
James Waldron
Apr 21, 2026 10:41am
GSK CEO’s ‘scientific courage’ propels ADC toward ph. 3 tests
Apr 12, 2026 10:10am
Regeneron's obesity drug shows Zepbound-like efficacy in phase 3
Mar 9, 2026 8:25am
GSK says 'stay tuned' for more ADC data as Hansoh posts 49% ORR
Oct 19, 2025 10:40am
Hansoh, Chugai ink separate and lucrative licensing agreements
Oct 17, 2025 11:04am
Regeneron pens $2B pact for Hansoh's potential rival to Zepbound
Jun 2, 2025 8:20am
